FDA — authorised 28 June 2012
- Application: NDA202611
- Marketing authorisation holder: APGDI
- Local brand name: MYRBETRIQ
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 Bladogra in United States
FDA authorised Bladogra on 28 June 2012
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Bladogra approved in United States?
Yes. FDA authorised it on 28 June 2012.
Who is the marketing authorisation holder for Bladogra in United States?
APGDI holds the US marketing authorisation.